Successful osimertinib treatment for leptomeningeal carcinomatosis from lung adenocarcinoma with the T790M mutation of EGFR

Por Sakai, Hitomi, Hayashi, Hidetoshi, Iwasa, Tsutomu, Hasegawa, Yoshikazu, Takeda, Masayuki, Nakagawa, Kazuhiko
Publicado no ESMO Open (2017)

Laparoscopic Wedge Resection of Gastric Stromal Tumor (GIST)

Por Samardzic, Josip, Hreckovski, Boris, Hasukic, Ismar, Hasukic, Sefik
Publicado no Med Arch (2015)

Prophylactic Management of Radiation-Induced Nausea and Vomiting

Por Feyer, Petra, Jahn, Franziska, Jordan, Karin
Publicado no Biomed Res Int (2015)

Life-threatening colitis and complete response with ipilimumab in a patient with metastatic BRAF-mutant melanoma and rheumatoid arthritis

Por Aya, Francisco, Gaba, Lydia, Victoria, Ivan, Fernandez-Martinez, Aranzazu, Ruiz-Esquide, Virginia, Pineda, Estela, Tosca, Monica, Viladot, Margarita, Pereira, Veronica, Malvehy, Josep, Prat, Aleix, Arance, Ana
Publicado no ESMO Open (2016)

Unravelling signal escape through maintained EGFR activation in advanced non-small cell lung cancer (NSCLC): new treatment options

Por Remon, Jordi, Besse, Benjamin
Publicado no ESMO Open (2016)

Challenge of cancer in the elderly

Por Marosi, Christine, Köller, Marcus
Publicado no ESMO Open (2016)

Highlights in breast cancer from ASCO 2016

Por Cardoso, Fatima
Publicado no ESMO Open (2016)

Emerging challenges of advanced squamous cell lung cancer

Por Zhang, Yi-Chen, Zhou, Qing, Wu, Yi-Long
Publicado no ESMO Open (2017)

Cancer in pregnancy: disentangling treatment modalities

Por Zagouri, Flora, Dimitrakakis, Constantine, Marinopoulos, Spyridon, Tsigginou, Alexandra, Dimopoulos, Meletios-Athanassios
Publicado no ESMO Open (2016)

Renal insufficiency and cancer treatments

Por Launay-Vacher, Vincent, Janus, Nicolas, Deray, Gilbert
Publicado no ESMO Open (2016)

NTRK gene fusions as novel targets of cancer therapy across multiple tumour types

Por Amatu, Alessio, Sartore-Bianchi, Andrea, Siena, Salvatore
Publicado no ESMO Open (2016)

Can we predict toxicity and efficacy in older patients with cancer? Older patients with colorectal cancer as an example

Por Winther, Stine Braendegaard, Jørgensen, Trine Lembrecht, Pfeiffer, Per, Qvortrup, Camilla
Publicado no ESMO Open (2016)

ASCO highlights podcast: head and neck cancers

Por Merlano, Marco
Publicado no ESMO Open (2016)

TKI-induced pure red cell aplasia: first case report of pure red cell aplasia with both imatinib and nilotinib

Por Poudyal, Bishesh Sharma, Tuladhar, Sampurna, Gyawali, Bishal
Publicado no ESMO Open (2016)

Critically ill patients with cancer: chances and limitations of intensive care medicine—a narrative review

Por Schellongowski, Peter, Sperr, Wolfgang R, Wohlfarth, Philipp, Knoebl, Paul, Rabitsch, Werner, Watzke, Herbert H, Staudinger, Thomas
Publicado no ESMO Open (2016)

Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence

Por Troiani, Teresa, Napolitano, Stefania, Della Corte, Carminia Maria, Martini, Giulia, Martinelli, Erika, Morgillo, Floriana, Ciardiello, Fortunato
Publicado no ESMO Open (2016)

Molecular pathology of cancer: how to communicate with disease

Por Birner, Peter, Prager, Gerald, Streubel, Berthold
Publicado no ESMO Open (2016)

Tumour network in glioma

Por Winkler, Frank
Publicado no ESMO Open (2016)

Highlights from the San Antonio Breast Cancer Symposium 2015

Por Jassem, Jacek
Publicado no ESMO Open (2016)

Twenty years of anti-HER2 therapy-associated cardiotoxicity

Por Pondé, Noam F, Lambertini, Matteo, de Azambuja, Evandro
Publicado no ESMO Open (2016)